Issue navigation
Volume 78, Issue 1, January 2023
Reviews
Subcutaneously administered antibiotics: a review
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 1–7, https://doi.org/10.1093/jac/dkac383
Applications of the hollow-fibre infection model (HFIM) in viral infection studies
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 8–20, https://doi.org/10.1093/jac/dkac394
Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 21–30, https://doi.org/10.1093/jac/dkac404
Systematic reviews
Systematic review of surveillance systems for AMR in Africa
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 31–51, https://doi.org/10.1093/jac/dkac342
Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 52–77, https://doi.org/10.1093/jac/dkac346
Original research
Investigating the immunomodulatory activities of omadacycline
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 78–83, https://doi.org/10.1093/jac/dkac356
Characteristics of the sore throat test and treat service in community pharmacies (STREP) in Wales: cross-sectional analysis of 11 304 consultations using anonymized electronic pharmacy records
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 84–92, https://doi.org/10.1093/jac/dkac358
In vivo pharmacokinetics and pharmacodynamics of ceftibuten/ledaborbactam, a novel oral β-lactam/β-lactamase inhibitor combination
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 93–100, https://doi.org/10.1093/jac/dkac359
In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 101–107, https://doi.org/10.1093/jac/dkac360
Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 108–116, https://doi.org/10.1093/jac/dkac361
Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 117–121, https://doi.org/10.1093/jac/dkac362
Multiomics characterization of methicillin-resistant Staphylococcus aureus (MRSA) isolates with heterogeneous intermediate resistance to vancomycin (hVISA) in Latin America
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 122–132, https://doi.org/10.1093/jac/dkac363
EnvR is a potent repressor of acrAB transcription in Salmonella
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 133–140, https://doi.org/10.1093/jac/dkac364
Sitafloxacin pharmacokinetics/pharmacodynamics against multidrug-resistant bacteria in a dynamic urinary tract infection in vitro model
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 141–149, https://doi.org/10.1093/jac/dkac365
GyrB in silico mining in 27 151 global gonococcal genomes from 1928–2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 150–154, https://doi.org/10.1093/jac/dkac366
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 155–160, https://doi.org/10.1093/jac/dkac367
Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 161–168, https://doi.org/10.1093/jac/dkac369
The antiviral efficacies of small-molecule inhibitors against respiratory syncytial virus based on the F protein
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 169–179, https://doi.org/10.1093/jac/dkac370
High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 180–184, https://doi.org/10.1093/jac/dkac372
Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 185–195, https://doi.org/10.1093/jac/dkac373
The effect of duration of therapy for treatment of Staphylococcus aureus blood stream infection: an application of cloning to deal with immortal-time bias in an analysis of data from a cohort study (BSI-FOO)
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 196–204, https://doi.org/10.1093/jac/dkac374
Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feeding
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 205–208, https://doi.org/10.1093/jac/dkac375
Full-length whole-genome sequencing analysis of emerged meropenem-resistant mutants during long-term in vitro exposure to meropenem for borderline meropenem-susceptible carbapenemase-producing and non-carbapenemase-producing Enterobacterales
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 209–215, https://doi.org/10.1093/jac/dkac376
Decreased cyclic-AMP caused by ATP contributes to fosfomycin heteroresistance in avian Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 216–224, https://doi.org/10.1093/jac/dkac377
EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 225–231, https://doi.org/10.1093/jac/dkac378
Diffusion of amoxicillin into heart valves from infective endocarditis patients
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 232–237, https://doi.org/10.1093/jac/dkac379
In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 238–241, https://doi.org/10.1093/jac/dkac380
Outpatient purchasing patterns of hydroxychloroquine and ivermectin in the USA and Canada during the COVID-19 pandemic: an interrupted time series analysis from 2016 to 2021
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 242–251, https://doi.org/10.1093/jac/dkac382
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 252–256, https://doi.org/10.1093/jac/dkac385
A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 257–262, https://doi.org/10.1093/jac/dkac386
Synergy of outer membrane disruptor SLAP-S25 with hydrophobic antibiotics against Gram-negative pathogens
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 263–271, https://doi.org/10.1093/jac/dkac387
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 272–275, https://doi.org/10.1093/jac/dkac388
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 276–283, https://doi.org/10.1093/jac/dkac389
Retrospective study of outcomes of short versus long duration of antibiotic therapy for residual osteomyelitis in surgically resected diabetic foot infection
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 284–288, https://doi.org/10.1093/jac/dkac390
Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 289–295, https://doi.org/10.1093/jac/dkac396
Pharmacokinetics and soft-tissue distribution of tebipenem pivoxil hydrobromide using microdialysis: a study in healthy subjects and patients with diabetic foot infections
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 296–301, https://doi.org/10.1093/jac/dkac399
The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 302–308, https://doi.org/10.1093/jac/dkac405
Research letters
Evaluation of antifungal use in long-term care facilities using pharmacy dispensing data in the USA, 2019
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 309–311, https://doi.org/10.1093/jac/dkac384
Complete genome sequence and characterization of Clostridium perfringens type D carrying optrA-plasmid and Tn6218-like transposon
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 311–313, https://doi.org/10.1093/jac/dkac393
Letters to the Editor
Comment on: Comparison of three lateral flow immunochromatographic assays for the rapid detection of KPC, NDM, IMP, VIM and OXA-48 carbapenemases in Enterobacterales
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 314–317, https://doi.org/10.1093/jac/dkac381
Comment on: Identification of a novel tedizolid resistance mutation in rpoB of MRSA after in vitro serial passage
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 317–318, https://doi.org/10.1093/jac/dkac397
Correction
Correction to: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 1, January 2023, Pages 319–320, https://doi.org/10.1093/jac/dkac371
